Haleon plc (NYSE:HLN) Shares Sold by EP Wealth Advisors LLC

EP Wealth Advisors LLC reduced its stake in shares of Haleon plc (NYSE:HLN) by 13.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,326 shares of the company’s stock after selling 3,656 shares during the period. EP Wealth Advisors LLC’s holdings in Haleon were worth $223,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Sierra Ocean LLC acquired a new position in shares of Haleon during the 4th quarter worth approximately $26,000. Geneos Wealth Management Inc. purchased a new stake in Haleon in the 4th quarter worth approximately $35,000. FIL Ltd grew its stake in Haleon by 45.7% in the 4th quarter. FIL Ltd now owns 4,049 shares of the company’s stock worth $39,000 after acquiring an additional 1,270 shares during the period. Spire Wealth Management purchased a new stake in Haleon in the 4th quarter worth approximately $39,000. Finally, Addison Advisors LLC grew its stake in Haleon by 28.7% in the 4th quarter. Addison Advisors LLC now owns 4,954 shares of the company’s stock worth $47,000 after acquiring an additional 1,106 shares during the period. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Down 2.3%

Shares of NYSE HLN opened at $10.46 on Wednesday. Haleon plc has a 52-week low of $8.25 and a 52-week high of $10.85. The firm has a fifty day moving average of $10.21 and a 200-day moving average of $9.85. The stock has a market capitalization of $47.18 billion, a PE ratio of 30.76, a P/E/G ratio of 2.82 and a beta of 0.24. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. On average, analysts anticipate that Haleon plc will post 0.43 EPS for the current year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be given a dividend of $0.1166 per share. This represents a yield of 1.6%. This is a boost from Haleon’s previous — dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon’s dividend payout ratio is 58.97%.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. HSBC reaffirmed a “hold” rating on shares of Haleon in a research note on Wednesday, March 5th. Morgan Stanley raised shares of Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 target price for the company in a research note on Friday, May 9th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Barclays reissued an “overweight” rating on shares of Haleon in a research note on Tuesday, May 6th. Finally, Hsbc Global Res cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Five research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $11.25.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.